Parkinson Association of Santa Barbara 2024 Symposium

Laurie Mischley studied naturopathic medicine (ND) at Bastyr University and epidemiology (MPH) and nutritional sciences (PhD) at the University of Washington and she maintains appointments at both Universities. Her work is focused on identifying the nutritional requirements unique to individuals with Parkinson’s Disease (PD) and has published on coenzyme Q10, lithium, glutathione, NAD+, and ATP deficiency (www.lauriemischley.com). She is Principal Investigator of the Modifiable Variables in Parkinsonism (MVP) Study (MVP-study.com), which is attempting to describe why some people with PD progress slower than others. She is working on ways to study, package and deliver evidence-based lifestyle modification as a therapeutic strategy. She founded the canine scent-based PD screening tool, ParK-9 (www.Park-9.com), developed the Parkinson Symptom Tracking (PRO-PD) App to quantify PD severity (www.PD-symptoms.com), and is instructor of the online series, Parkinson School (www.Parkinson-School.com) and Parkinson Summer Camp (www.BastyrPDSchool.org). Dr. Mischley maintains a clinical practice at Seattle Integrative Medicine (www.SeattleIntegrativeMedicine.com).

Jeff Bronstein received his bachelor’s degree from the University of California, Berkeley and M.D. and Ph.D. from UCLA as a recipient of the Medical Scientist Training Program Award. He completed a residency in Neurology and fellowship training in Movement Disorders at UCLA and at Queens Square in London. Dr. Bronstein also completed a postdoctoral fellowship in molecular biology before being appointed Director of the Movement Disorders Program at UCLA in 1996. Professor of Neurology in 2006, and Professor of Molecular Toxicology in 2007. He directs a Wilson’s Disease Association Center of Excellence and a basic science laboratory investigating the causes of Parkinson’s disease (environmental and genetic) using cell and zebrafish models as well as population-based studies. His clinical interests include the medical and surgical management of Parkinson’s disease, Wilson’s disease and other movement disorders. Dr. Bronstein active research program includes clinical trials to develop new therapies.